Goldline Pharmaceutical Ltd.BSE: GLPL

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

· Issued by Goldline Pharmaceutical Ltd. via BSE India

Filed with BSE · · 2 pages · English

Summary by 6ix AI

The certificate confirms that all shares of the company are held in dematerialized form and no requests for dematerialization were received during the quarter. This filing serves to inform the BSE about the compliance status regarding shareholding.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Sub: Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June, 2026. Sir / Ma’am, We hereby enclose a certificate under regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June, 2026 received from M/s. Bigshare Services Private Limited, Registrar and Share Transfer Agent of our c

Goldline Pharmaceutical Ltd. on 6ix

Earlier from Goldline Pharmaceutical

Later from Goldline Pharmaceutical

All Goldline Pharmaceutical news releases